All you need to get started with ETF selection and analysis. Create your account now →
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
AAKG ETF · ARK Genomic Revolution UCITS ETF
The AAKG Exchange Traded Fund (ETF) is provided by ARK Invest Europe. This fund is actively managed; it does not track an index. The dividend policy is capitalization.
Real-time data unavailable for AAKG
LIVE
CLOSED
This fund is part ofWorld Blended Cap1M perf.-3.65%
Last price
N/A
1M perf.
-5.74%
1M flows
-€47K
AuM
€39M
E/R
0.75%
Rating
Not rated
ESG Consensus®
AAKG
N/A
Performance & flows
Segment for quartile rank
December 12, 2025 → March 12, 2026
Create a free account to view the flows graph
AAKG
$4.94
-12.46%
World Blended Cap
+0.97%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -5.74%  | -12.46% | +15.47% | N/A | N/A | -12.33% | -8.87% | -8.87% | |
| Flows |
Key fund info
Segment for quartile rank
Main characteristics
More details
NAV
3/12/2026
$4.94
1D NAV change
-5.41%
Dividend policy
No. of holdings
35
Inception date
4/12/2024
Jurisdiction
Ireland
Distribution
Spain
Austria
Denmark
Finland
Germany
Legal structure
Irish Collective Asset-management Vehicle
Base currency
USD
Classification
Investment strategy
ARK Genomic Revolution UCITS ETF is an exchange-traded fund incorporated in Ireland. The Fund will invest in companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to genomics revolution.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs
ARKG
1M perf.
-3.62%
E/R
0.75%
CURE
1M perf.
+0.18%
E/R
0.45%
XBI
1M perf.
-0.80%
E/R
0.35%
XPH
1M perf.
-6.46%
E/R
0.35%
PTH
1M perf.
-1.98%
E/R
0.72%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -12.46% | +15.47%  | N/A | N/A |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
1
2
3
4
5
6
7
PRIIPS
1
2
3
4
5
6
7
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
USA
92.62%
Switzerland
7.38%
Sectors
Health Care
86.66%
Information Technology
1.09%
Unavailable
12.24%
Diversification
Total weight of top 15 holdings out of 35
Top 15 holdings
Data as of January 31, 2026
TWIST BIOSCIENCE CORP
CRISPR THERAPEUTICS
US88023B1035
PERSONALIS INC
BEAM THERAPEUTICS
10X GENOMICS INC
ILLUMINA
NATERA
Create a free account to view top holdings
RECURSION PHARMACEUTICALS
INTELLIA THERAPEUTICS INC
GUARDANT HEALTH INC
CAREDX INC/D
VERACYTE INC/D
ABSCI
NURIX THERAPEUTICS
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
Yes
SDG
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
ARK Invest Europe
ARK Invest Europe ID Card
Number of funds
10
Total AuM
€901M
Expense ratio range
0.45% - 0.75%
Average expense ratio
0.58%
Top 5 funds by ARK Invest Europe
| AuM | ||
|---|---|---|
AAKI | ARK Artificial Intelligence & Robotics UCITS ETF | €259M |
ARXK | ARK Innovation UCITS ETF | €240M |
WRLD | Rize Environmental Impact 100 UCITS ETF | €110M |
CYBR | Rize Cybersecurity and Data Privacy UCITS ETF | €88M |
RIZF | Rize Sustainable Future of Food UCITS ETF | €72M |
The details about this provider will be added soon.
Frequently asked questions about AAKG
What does ARK Genomic Revolution UCITS ETF, AAKG, invest in?
AAKG is a Active ETF. This ETF provides exposure to Other Equities.
What is the Total Expense ratio (TER) of AAKG?
AAKG carries a total expense ratio (TER) of 0.75%, indicating the annual cost for holding the fund.
When was AAKG launched?
AAKG was introduced to the market on April 12, 2024. It trades on Spain, among other exchanges
Who is the ETF issuer of AAKG?
ARK Genomic Revolution UCITS ETF, AAKG, is provided by ARK Invest Europe. Learn more about ARK Invest Europe here.
What is the current assets under management (AUM) of AAKG?
AAKG oversees €39M in assets as of March 12, 2026.
How has AAKG performed lately?
Based on data from March 12, 2026, AAKG returned -5.74% over the past month, -12.46% over the last three months and -8.87% year-to-date.
What are the latest inflows or outflows for AAKG?
As of March 12, 2026, AAKG recorded net flows of -€51K over the last month and +€5.9M year-to-date.
Does AAKG distribute dividends?
AAKG follows a capitalizing, meaning it reinvests income within the fund.
What are the main country or region exposures of AAKG?
As of January 31, 2026, AAKG has significant geographic allocations in USA and Switzerland.
In which sector or theme does AAKG invest in?
As of January 31, 2026, AAKG focuses largely on Health Care and Information Technology.
How many securities does AAKG hold and how diversified is it?
As of January 31, 2026, AAKG holds 35 positions in its portfolio, with 73.31% of assets concentrated in its top 15 holdings.
What are the main positions in AAKG?
As of January 31, 2026, AAKG top three holdings include TWIST BIOSCIENCE CORP, CRISPR THERAPEUTICS and US88023B1035.
What is the base currency of AAKG?
The base currency of AAKG is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
